Evidence map›Paper›PMID 25648237›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Duration of Colonization and Determinants of Earlier Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.

Valerie C Cluzet, Jeffrey S Gerber, Irving Nachamkin, Joshua P Metlay, Theoklis E Zaoutis, Meghan F Davis, Kathleen G Julian, David Royer, Darren R Linkin, Susan E Coffin and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Urease promotes pH homeostasis and growth ofJournal of bacteriology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Stopping Household Methicillin-resistant Staphylococcusaureus Transmission and Recurrent Infections: An Unmet Challenge.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Impact of Systemic Antibiotics on Staphylococcus aureus Colonization and Recurrent Skin Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 2 countries.

Valerie C CluzetDivision of Infectious Diseases, Department of Medicine.
Jeffrey S GerberCenter for Clinical Epidemiology and Biostatistics Department of Biostatistics and Epidemiology Department of Pediatrics Division of Infectious Diseases, Children's Hospital of Philadelphia.
Irving NachamkinDepartment of Pathology and Laboratory Medicine.
Joshua P MetlayDepartment of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston.
Theoklis E ZaoutisCenter for Clinical Epidemiology and Biostatistics Department of Biostatistics and Epidemiology Department of Pediatrics Division of Infectious Diseases, Children's Hospital of Philadelphia.
Meghan F DavisDepartment of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Kathleen G JulianDivision of Infectious Diseases, Penn State Hershey Medical Center.
David RoyerDepartment of Biology, Lincoln University, Pennsylvania.
Darren R LinkinDivision of Infectious Diseases, Department of Medicine Philadelphia Veterans Administration Medical Center.
Susan E CoffinCenter for Clinical Epidemiology and Biostatistics Department of Biostatistics and Epidemiology Department of Pediatrics Division of Infectious Diseases, Children's Hospital of Philadelphia.
David J MargolisCenter for Clinical Epidemiology and Biostatistics Department of Biostatistics and Epidemiology Department of Dermatology, Perelman School of Medicine, University of Pennsylvania.
Judd E HollanderDepartment of Emergency Medicine, Thomas Jefferson University Hospital, Philadelphia.
Rakesh D MistrySection of Emergency Medicine, Children's Hospital Colorado, Aurora.
Laurence J GavinDepartment of Emergency Medicine, Penn Presbyterian Medical Center.
Pam TolomeoCenter for Clinical Epidemiology and Biostatistics.
Jacqueleen A WiseCenter for Clinical Epidemiology and Biostatistics.
Mary K WheelerCenter for Clinical Epidemiology and Biostatistics.
Warren B BilkerCenter for Clinical Epidemiology and Biostatistics Department of Biostatistics and Epidemiology.
Xiaoyan HanCenter for Clinical Epidemiology and Biostatistics Department of Biostatistics and Epidemiology.
Baofeng HuDepartment of Pathology and Laboratory Medicine.
Neil O FishmanDivision of Infectious Diseases, Department of Medicine.
Ebbing LautenbachDivision of Infectious Diseases, Department of Medicine Center for Clinical Epidemiology and Biostatistics Department of Biostatistics and Epidemiology.
Center for Clinical Research (United States) · USOffice of Infectious Diseases · USChildren's Hospital of Philadelphia · USJohns Hopkins University · USLincoln University - Pennsylvania · USMassachusetts General Hospital · USPenn State Milton S. Hershey Medical Center · USPresbyterian Medical Center · KRThomas Jefferson University Hospital · USUniversity of Colorado Denver · US

Funding

Cardiology & pulmonary research training grantT32HL007891 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI Jason D Christie · 1998 to 2026
$12.0M
Infectious Diseases Epidemiology Training GrantT32AI055435 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2003 to 2023
$6.9M
CLINICAL RESEARCH TRAINING IN KIDNEY DISEASET32DK007785 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI FELDMAN, HAROLD I · 2000 to 2019
$3.9M
Mentoring and patient-oriented research in antimicrobial resistanceK24AI080942 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2009 to 2013
$853k
NCEZID CDC HHS U54 CK000163NCEZID CDC HHS U54-CK000163NIAID NIH HHS K24 AI080942NIAID NIH HHS K24-AI080942
6 · The paper itself

Abstract

backgroundThe duration of colonization and factors associated with clearance of methicillin-resistant Staphylococcus aureus (MRSA) after community-onset MRSA skin and soft-tissue infection (SSTI) remain unclear.

methodsWe conducted a prospective cohort study of patients with acute MRSA SSTI presenting to 5 adult and pediatric academic hospitals from 1 January 2010 through 31 December 2012. Index patients and household members performed self-sampling for MRSA colonization every 2 weeks for 6 months. Clearance of colonization was defined as negative MRSA surveillance cultures during 2 consecutive sampling periods. A Cox proportional hazards regression model was developed to identify determinants of clearance of colonization.

resultsTwo hundred forty-three index patients were included. The median duration of MRSA colonization after SSTI diagnosis was 21 days (95% confidence interval [CI], 19-24), and 19.8% never cleared colonization. Treatment of the SSTI with clindamycin was associated with earlier clearance (hazard ratio [HR], 1.72; 95% CI, 1.28-2.30; P < .001). Older age (HR, 0.99; 95% CI, .98-1.00; P = .01) was associated with longer duration of colonization. There was a borderline significant association between increased number of household members colonized with MRSA and later clearance of colonization in the index patient (HR, 0.85; 95% CI, .71-1.01; P = .06).

conclusionsWith a systematic, regular sampling protocol, duration of MRSA colonization was noted to be shorter than previously reported, although 19.8% of patients remained colonized at 6 months. The association between clindamycin and shorter duration of colonization after MRSA SSTI suggests a possible role for the antibiotic selected for treatment of MRSA infection.

Indexed as

AdolescentAdultAnti-Bacterial AgentsCarrier StateChildChild, PreschoolCohort StudiesCommunity-Acquired InfectionsFemaleHumansLongitudinal StudiesMaleMethicillin-Resistant Staphylococcus aureusPrevalenceProspective StudiesStaphylococcal InfectionsAnti-Bacterial Agentsmethicillin-resistant Staphylococcus aureus (MRSA)MRSA colonizationMRSA decolonizationMRSA skin and soft-tissue infection

Identifiers

PMID25648237
PMCPMC4490328
OpenAlexW2151323108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.